Bifeng Ding

Pharmacokinetics and Dose Recommendations for Cyclosporine and Tacrolimus When Coadministered With ABT-450, Ombitasvir, and Dasabuvir

Prajakta Badri, Sheetij Dutta, Eoin Coakley et al. · American Journal of Transplantation · 2015 · 84 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Pharmacokinetics and safety of co-administered paritaprevir plus ritonavir, ombitasvir, and dasabuvir in hepatic impairment

Amit Khatri, Rajeev Menon, Thomas Marbury et al. · Journal of Hepatology · 2015 · 44 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

Drug–Drug Interactions Between the Anti-Hepatitis C Virus 3D Regimen of Ombitasvir, Paritaprevir/Ritonavir, and Dasabuvir and Eight Commonly Used Medications in Healthy Volunteers

Akshanth R. Polepally, Jennifer R. King, Bifeng Ding et al. · Clinical Pharmacokinetics · 2016 · 30 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Pharmacokinetics of Tacrolimus and Cyclosporine in Liver Transplant Recipients Receiving 3 Direct-Acting Antivirals as Treatment for Hepatitis C Infection

Prajakta Badri, Apurvasena Parikh, Eoin Coakley et al. · Therapeutic Drug Monitoring · 2016 · 30 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Drug-Drug Interactions between Sofosbuvir and Ombitasvir-Paritaprevir-Ritonavir with or without Dasabuvir

Jennifer R. King, Sandeep Dutta, Daniel E. Cohen et al. · Antimicrobial Agents and Chemotherapy · 2015 · 20 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17